Eli Lilly and Company, a global leader in pharmaceutical innovation, has announced a significant strategic alliance with Profluent, an artificial…
Read More
US Food and Drug Administration Unveils Draft Guidance for Genome Editing Therapies, Prioritizing Safety Through Next-Generation Sequencing
The US Food and Drug Administration (FDA) has issued draft guidance aimed at enhancing the safety assessment of genome editing…
Read More
The biotech bi-weekly: genome editing, life-extending therapeutics, an early-stage biotech hub and more
The biopharmaceutical and biotechnology sectors have recently experienced an extraordinary period of accelerated activity, marked by a rapid succession of…
Read More
